Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Flow Cytometry In Oncology And Immunology Market Growth From $2.56 Billion In 2026 To $3.82 Billion By 2030 At A CAGR Of 10.5%
The flow cytometry in oncology and immunology market size has experienced rapid expansion in recent years. This market is projected to grow from $2.32 billion in 2025 to $2.56 billion in 2026, showcasing a compound annual growth rate (CAGR) of 10.2%. The historical growth within this sector can be attributed to increased funding for cancer research, the expansion of immunotherapy development, the availability of advanced cytometry platforms, heightened clinical trial activity, and a rising demand for immune monitoring.
The flow cytometry in oncology and immunology market size is projected for significant expansion over the next few years. This market is anticipated to reach $3.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. The projected growth is largely driven by factors such as the demand for personalized oncology diagnostics, integration with genomic data, the expansion of immuno-oncology therapies, a broadening of clinical research pipelines, and progress in multiplex analysis. Prominent trends expected in the forecast period include the increasing use in cancer biomarker identification, greater adoption in immune cell profiling, the wider application of minimal residual disease detection, its growing role in translational research, and the integration of high-dimensional data analysis.
Get A Free Sample Report With In-Depth Market Insights:
Flow Cytometry In Oncology And Immunology Market Growth Momentum: What Factors Are Shaping Demand?
The increasing incidence of HIV/AIDS is projected to boost the expansion of flow cytometry within the oncology and immunology market. HIV, a virus, targets the body’s immune system, particularly its CD4 cells, which are vital white blood cells responsible for combating infections. Without treatment, HIV can progress to AIDS, representing the advanced stage of the infection. In both research and clinical contexts for HIV/AIDS, flow cytometry serves as an effective method for analyzing and characterizing cells, especially immune cells, by their physical and chemical attributes. This technique is capable of detecting T cells that are latently infected, meaning they contain the HIV genome but are not actively producing the virus. For example, data from UNAIDS, a UN program based in Switzerland, reported in July 2024 that the global population living with HIV in 2023 was around 39.9 million, an increase from 39.0 million in 2022. Consequently, the growing occurrence of HIV/AIDS is a key factor propelling the flow cytometry market in oncology and immunology.
Flow Cytometry In Oncology And Immunology Market Segment Landscape And Growth Outlook
The flow cytometry in oncology and immunology market covered in this report is segmented –
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation
Flow Cytometry In Oncology And Immunology Market Trends: What’s Defining The Industry’s Next Phase?
Major companies in the flow cytometry sector within the oncology and immunology market are focused on developing innovative solutions, such as spectral flow cytometry, to gain a competitive advantage. Spectral flow cytometry is a technology designed to capture the full emission spectrum of each fluorescent marker, rather than detecting fixed, narrow-band signals, thereby enabling much higher parameter, multiparametric cell analysis. For instance, in May 2024, Agilent Technologies, a US-based life science company, unveiled the NovoCyte Opteon spectral flow cytometer, which supports three to five lasers, incorporates up to 73 detectors, and facilitates the analysis of more than 40 markers in a single run. This system bolsters the capacity for deep immunophenotyping in oncology and immunology research. Its advantages include flexibility in panel design, reduced spectral overlap, and improved signal resolution; however, it necessitates more complex data unmixing algorithms, which could potentially extend analysis time.
Flow Cytometry In Oncology And Immunology Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the flow cytometry in oncology and immunology market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, Miltenyi Biotec, Luminex Corporation, Q2 Solutions LLC, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
View The Full Flow Cytometry In Oncology And Immunology Market Report:
Flow Cytometry In Oncology And Immunology Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2025. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
